title: Serum resistin level in obese male children.
abstract: Objectives. Resistin is a member of cysteine-rich molecules. Several studies have been carried out to determine the biological effect of resistin, nevertheless a significant number are animal studies. All the studies performed regarding the relationship between serum resistin and obesity were merely accomplished in women. To the best of our knowledge, there is no survey on the correlation of the serum resistin level and obesity in male children. The aim of the present study is to assess serum concentration of resistin in obese male children. Methods. Between June 2009 and January 2010, we enrolled 42 randomly selected obese male students (body mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-eight healthy age-matched male students with normal BMI (<85th percentile) were selected as a control group for the purpose of comparison of the serum resistin levels. Results. Serum resistin levels were measured in obese and control group. No significant difference was found between resistin levels of the 2 groups (obese: 9.21 ± 5.6 ng/mL versus normal: 9.83 ± 4.3 ng/mL; P = .582). There was no significant correlation between serum resistin level and BMI. Assessing the resistin level in male subjects was the distinct feature of our study. The outstanding finding of this research is that there is no correlation between serum resistin level and obesity. Conclusion. We have demonstrated that there is no correlation between obesity in male children and resistin level. Consequently, metabolic abnormalities of insulin resistance seen in obese male patients are not related to resistin.
authors: Department of Pediatrics, Namazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
authors: Anis
authors: A
authors: Amirhakimi
authors: Hamdollah
authors: H
authors: Karamifar
authors: Hosein
authors: H
authors: Moravej
authors: Gholamhosein
authors: G
authors: Amirhakimi
references: Diabetes. 2003 Jul;52(7):1779-85
references: 12829646
references: Clin Endocrinol (Oxf). 2006 Apr;64(4):355-65
references: 16584505
references: Obes Res. 2004 Jun;12(6):962-71
references: 15229336
references: Nutr Rev. 2002 Oct;60(10 Pt 2):S1-14; discussion S68-84, 85-7
references: 12403078
references: J Clin Endocrinol Metab. 2004 Jun;89(6):2665-71
references: 15181039
references: Int J Colorectal Dis. 2010 Feb;25(2):205-12
references: 19888587
references: Eur J Endocrinol. 2002 Nov;147(5):571-4
references: 12444887
references: Mol Genet Metab. 2005 May;85(1):61-9
references: 15862282
references: Lancet. 2002 Jan 5;359(9300):46-7
references: 11809189
references: Endocrine. 2006 Feb;29(1):81-90
references: 16622295
references: Am J Med. 2006 May;119(5 Suppl 1):S10-6
references: 16563942
references: J Zhejiang Univ Sci B. 2008 Jan;9(1):44-50
references: 18196612
references: Clin Sci (Lond). 2005 Sep;109(3):243-56
references: 16104844
references: J Clin Invest. 2000 Aug;106(4):473-81
references: 10953022
references: Nat Med. 2001 Aug;7(8):941-6
references: 11479627
references: Diabetes Care. 2002 Dec;25(12):2342-9
references: 12453983
references: N Engl J Med. 2001 Nov 1;345(18):1345-6
references: 11794158
references: Diabetes. 2002 Jun;51(6):1737-44
references: 12031960
references: Circ Res. 2005 May 27;96(10):1042-52
references: 15920027
references: Diabetes. 2001 Oct;50(10):2199-202
references: 11574398
references: Acta Med Indones. 2010 Apr;42(2):74-7
references: 20513930